Skip to main content
Tanvex BioPharma, Inc. (TPE:6541)
Taiwan flag Taiwan · Delayed Price · Currency is TWD
55.60
+0.60 (1.09%)
May 14, 2025, 1:30 PM CST

Revenue by Product

Fiscal year is January - December.
Fiscal Year
 FY 2023 FY 2022 FY 2021 FY 2020
Period Ending
 Dec '23 Dec '22 Dec '21 Dec '20
Biopharmaceuticals
61.41M
Log In
Log In
Log In
Biopharmaceuticals Growth
174.11%
Log In
Log In
Log In

Revenue by Geography

Fiscal year is January - December.
Fiscal Year
 FY 2023 FY 2022 FY 2021 FY 2020
Period Ending
 Dec '23 Dec '22 Dec '21 Dec '20
Taiwan
53.70M
Log In
Log In
Log In
Taiwan Growth
139.70%
Log In
Log In
Log In
United States
7.71M
Log In
Log In
Log In